Rockline Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Hold
340
0.08% 76
2026
Q1
$313K Hold
340
0.07% 80
2025
Q4
$365K Buy
+340
New +$325K 0.07% 72
2025
Q3
Sell
-3,565
Closed -$2.78M 105
2025
Q2
$2.78M Buy
3,565
+252
+8% +$196K 0.66% 45
2025
Q1
$2.74M Buy
3,313
+216
+7% +$180K 0.76% 47
2024
Q4
$2.39M Buy
3,097
+150
+5% +$124K 0.64% 50
2024
Q3
$2.61M Buy
2,947
+228
+8% +$205K 0.74% 47
2024
Q2
$2.46M Buy
2,719
+179
+7% +$143K 0.76% 42
2024
Q1
$1.98M Buy
2,540
+511
+25% +$364K 0.69% 49
2023
Q4
$1.18M Buy
+2,029
New +$1.18M 0.49% 54

Other funds holding LLY

Rockline Wealth Management's LLY Position: Q2 2026 in Review

Rockline Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 340 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #76.

Rockline Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.78M in Q2 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rockline Wealth Management held 340 shares of Eli Lilly worth $408K as of Q2 2026.
  • Rockline Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.08% of Rockline Wealth Management's portfolio in Q2 2026, its #76 holding.
  • Rockline Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Rockline Wealth Management's Eli Lilly position peaked at $2.78M in Q2 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rockline Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.